- Sapru, A
- Calfee, CS
- Liu, KD
- Kangelaris, K
- Hansen, H
- Pawlikowska, L
- Ware, LB
- Alkhouli, MF
- Abbot, J
- Matthay, MA
- et al.
Objective: Thombomodulin (TM) is an activator of protein C and a biomarker for endothelial injury. We hypothesized that (1) elevated plasma levels would be associated with clinical outcomes and (2) polymorphisms in the TM gene would be associated with plasma levels.